Amgen also tested MariTide in a population with Type 2 diabetes, a group that tends to lose less weight with the new obesity ...
Shares of Novo Nordisk jumped 1.3% after President Biden proposed expanding Medicare and Medicaid coverage for weight-loss ...
Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...
HHS proposed a rule Tuesday that, if enacted, would expand access to anti-obesity medications like Wegovy, Ozempic, and Mounjaro to millions of Medicare and Medicaid beneficiaries. The regulation ...
Current rules for the Medicare and Medicaid government health insurance programmes cover the use of drugs such as Mounjaro, ...
The proposal would slash out-of-pocket costs by as much as 95% for the drugs that can carry a price tag of $1,000 a month, ...
WASHINGTON - US President Joe Biden on Nov 26 proposed expanding coverage of anti-obesity drugs for millions on Medicare and ...
Scots will need a higher body mass index than people in England before they can be given so-called 'fat jabs' on the NHS.
Obesity experts have said that nearly 20% patients may not respond well to GLP-1 medications. They explained that these drugs do not work on one-size-fits-all principle.
Popular weight-loss drugs like Ozempic and Mounjaro need to be taken exactly as prescribed. A doctor is sounding the alarm ...
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...